ANALYSIS OF GENE-EXPRESSION IN OSTEOGENIC CULTURED MARROW HYDROXYAPATITE CONSTRUCT IMPLANTED AT ECTOPIC SITES - A COMPARISON WITH THE OSTEOGENIC ABILITY OF CANCELLOUS BONE
Citation
T. Yoshikawa et al., ANALYSIS OF GENE-EXPRESSION IN OSTEOGENIC CULTURED MARROW HYDROXYAPATITE CONSTRUCT IMPLANTED AT ECTOPIC SITES - A COMPARISON WITH THE OSTEOGENIC ABILITY OF CANCELLOUS BONE, Journal of biomedical materials research, 41(4), 1998, pp. 568-573
Categorie Soggetti
Materials Science, Biomaterials","Engineering, Biomedical
SICI code
0021-9304(1998)41:4<568:AOGIOC>2.0.ZU;2-1
Abstract
We investigated the in vivo osteogenic ability of cultured marrow cell
s subcultured in porous hydroxyapatite. This osteogenic ability was co
mpared with that of cancellous bone grafts. Fresh marrow cells were ob
tained from young adult rat femora and cultured in a standard medium f
or 10 days, then trypsinized and used to make constructs of porous hyd
roxyapatite (HA) and cultured marrow cells. An additional 2-week cultu
re (subculture) was performed for the construct in standard medium wit
h and without the addition of dexamethasone (Dex). The 2-week subcultu
red constructs then were implanted into subcutaneous sites of syngenei
c rats. These implants and the rat cancellous bone were harvested and
prepared for gene expression analysis of alkaline phosphatase (ALP) an
d osteocalcin (OC) as well as for histological analysis. ALP and OC mR
NAs could be detected in Dex-treated subcultured constructs 1 week aft
er implantation, with an increase at 2 weeks, comparable to the observ
ation in cancellous bone. Histological analysis showed active bone for
mation even 1 week postimplantation. In contrast, the subcultured cons
tructs without the addition of Dex did not show bone formation, and on
ly small levels of ALP and OC mRNAs were found. These results indicate
that the bone tissue formed by grafting the Dex-treated construct of
cultured marrow cells and hydroxyapatite possesses a high osteoblastic
activity comparable to that of viable cancellous bone. Thus the prefa
bricated osteogenic subcultured marrow/HA construct may be applicable
in bone reconstructive surgery. (C) 1998 John Wiley & Sons, Inc. J Bio
med Mater Res, 41, 568-573, 1998.